Gosse Bote Bruinsma

Gosse Bote Bruinsma currently works at FAAH Pharma, Inc., as Chief Executive Officer and viDA Therapeutics, Inc., as Director.
Dr. Bruinsma also formerly worked at Axonyx, Inc., as President, Chief Executive Officer & Director in 2006, IDEA AG, as Chief Executive Officer & Member-Management Board from 2012 to 2014, Vivendy Therapeutics Ltd., as Chief Executive Officer from 2009 to 2013, Curidium Medica Ltd., as Executive Chairman from 2007 to 2009, Forest Laboratories, Inc., as Medical Director, GT Biopharma, Inc., as Director, ClinTrials Research, Inc., as Medical Director, VP-Medical & Regulatory Affairs, Agendia NV, as Director, Zambon Company SpA, as Medical Director-European Division, Opsona Therapeutics Ltd., as Non-Executive Director, Janssen Vaccines & Prevention BV, as Vice President-Development, and Chrysalis, as General Manager & Vice President-Development.
Dr. Bruinsma received his undergraduate degree from McGill University and doctorate degree from the University of Leiden.